In summary, beta-sitosterol, 16-epi-Isositsirikine, sinomenine, and stepholidine are the main substance bases for the treatment of RA in SA, and PTGS2, JUN, CASP3, and PPARG are the potential targets of action. Here, PTGS2 is linked to rheumatoid arthritis.